Northwestern Mutual Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-139	Closed	-$75	–	4024
2025 Q2	$75	Buy	+139	New	+$83	﹤0.01%	3567
2023 Q3	–	Sell	-385	Closed	-$501	–	3506
2023 Q2	$501	Buy	+385	New	+$526	﹤0.01%	3176
2021 Q4	–	Sell	-1,050	Closed	-$9K	–	3313
2021 Q3	$9K	Buy	+1,050	New	+$10.4K	﹤0.01%	2509
2020 Q3	–	Sell	-300	Closed	-$3K	–	2658
2020 Q2	$3K	Buy	+300	New	+$2.78K	﹤0.01%	2173
2018 Q4	–	Sell	-139	Closed	-$2K	–	2627
2018 Q3	$2K	Sell	139 -2,348	-94%	-$35.7K	﹤0.01%	2307
2018 Q2	$35K	Sell	2,487 -513	-17%	-$8.52K	﹤0.01%	1387
2018 Q1	$57K	Buy	+3,000	New	+$64.1K	﹤0.01%	1148
2017 Q4	–	Sell	-4,845	Closed	-$73K	–	2431
2017 Q3	$73K	Buy	+4,845	New	+$53.6K	﹤0.01%	985
2017 Q1	–	Sell	-100	Closed	–	–	2353
2016 Q4	$0	Buy	+100	New	+$364	﹤0.01%	2379

Other funds holding SGMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northwestern Mutual Wealth Management's SGMO Position: Q3 2025 in Review

Northwestern Mutual Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2025, closing a stake of 139 shares — an estimated $75 sold.

Northwestern Mutual Wealth Management first reported a position in SGMO in Q4 2016 and held it in 9 quarters. The position peaked at $73K in Q3 2017. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

Northwestern Mutual Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 139 SANGAMO THERAPEUTICS INC shares in Q3 2025, an estimated $75.
Northwestern Mutual Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 9 quarters.
Northwestern Mutual Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $73K in Q3 2017.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.